A worrisome case from Australia--where a pharmaceutical company sponsored publication of an "academic" journal through a medical/scientific publisher, Elsevier for a fee.
http://www.the-scientist.com/blog/print/55671/
hat tip to:
Therapeutics Initiative at UBC for the link: http://www.ti.ubc.ca/
The Terapeutics Initiative itself came under fire recently for refusing pharmaceutical influence:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2464479
No comments:
Post a Comment